Our Mission

---

Bridging the Gap Between Breakthrough & Patient Impact.

Developing novel therapeutics is an arduous journey. Too often, innovative ideas stall before reaching the clinic not because the science failed, but because the strategy was missing.

CellGene Nexus was founded to change that narrative. We bring deep, hands-on expertise in oncology, gene therapy, and translational research to help founders and researchers move from preclinical proof to clinical reality with certainty.

We don't just advise; we architect the path forward.

• 15+ years in oncology, translational, and regulatory science.
• Preclinical strategy & experimental design (cells & humanized mouse models) aligned to FDA IND standards.
• IND-enabling program development across tox, biodistribution, and efficacy studies (GLP-aware).
• 90+ peer-reviewed publications and global presentations in precision medicine.
• Deep roots in the Houston / Texas Medical Center innovation ecosystem.